You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

November 8, 2013

Dr. Atthachai Homhuan Explains the Dark Side of Online Pharmacies in BigChilli Interview

The BigChilli

Ordering drugs from online pharmacies can be a risky ordeal. Not only can they cause serious harm to your health, but they may expose you to credit card fraud and put you in a difficult position with the Thai authorities. Dr. Atthachai Homhuan, manager of the Regulatory Affairs group at Tilleke & Gibbins, recently expressed his views on this subject in an interview arranged by The BigChilli magazine, in which he explained some of the pitfalls of dealing with online pharmacies.

The prevalence of online pharmacies in Thailand is growing. “Online pharmacy websites are extremely popular in Thailand with the booming of the Internet and the social media,” Atthachai says. “Illegal online websites originating in Thailand are offering drugs banned or restricted by the Thai Food and Drug Administration (FDA),” he continues. This is problematic, because “The drugs could be counterfeit, expired, or could go bad during transport, which may cause serious harm or even death.” On top of this, Atthachai warns that “customers are at risk of legal action being taken against them by the FDA or Customs if banned or restricted drugs addressed to them are found, for example at a post office.” Also, “Credit card information can be stolen because most of the people running illegal online pharmacies are criminals,” and, moreover, “minors can order controlled substances.” Online pharmacies present a huge problem in Thailand, and they need to be stopped.

Speaking on behalf of Tilleke & Gibbins, Atthachai says, “We coordinate with the patent-holding company and if we can find the source of the counterfeits, we inform them and help provide appropriate measures to prevent and eradicate the problem.” He continues, saying “We will contact the FDA through our Intellectual Property Department and try to work out a solution.” In closing, he says, “If you suspect you have been given a counterfeit product, contact the FDA or our law firm. We will contact the company that makes the legitimate product to investigate the matter. We are working closely with the FDA, and if we can overcome this problem we can improve the quality of life in Thailand.”

The BigChilli is a lifestyle, business, and educational magazine based in Thailand. If you would like to read the full interview, please visit The BigChilli website.

RELATED INSIGHTS​ 

August 22, 2019
On August 29, Dr. Atthachai Homhuan, manager of Tilleke & Gibbins’ regulatory affairs practice, will be speaking at the CannaBiz Invest Asia Summit in a session entitled “Understanding the Medical Cannabis Investment Landscape & Regulatory Hurdles in Thailand.”
August 19, 2019
Tilleke & Gibbins is happy to share that two of the firm’s practitioners—Alan Adcock, partner and deputy director of intellectual property, and Siraprapha Rungpry, consultant—have been recognized as leading individuals in Who’s Who Legal: Life Sciences 2019 . Notably, only four practitioners in Thailand are listed for this industry, and Tilleke & Gibbins is the only firm housing more than one ranked individual.
July 26, 2019
Partners Thomas J. Treutler and Loc Xuan Le, representing the South-East Asia IPR SME Helpdesk, will speak to business mission delegates from European healthcare and medical device companies at two events in Ho Chi Minh City on July 31 and August 1. The events are part of the EU Business Avenues program, an EU-funded initiative helping European SMEs in various industries to extend their business to Southeast Asian markets.
July 9, 2019
In recognition of Tilleke & Gibbins’ pro bono practice, our firm has been nominated as “2019 Domestic Law Firm of the Year” at this year’s TrustLaw Awards. Our nomination in this category is based on our commitment to supporting pro bono projects through the TrustLaw Foundation over the past year, and is particularly distinctive as Tilleke & Gibbins is one of just three firms in the world, and the only firm in the Asia-Pacific region, under consideration for this award.